APOBEC2 and Miyoshi myopathy: Likewise, APOBEC3B and APOBEC2 upregulation has been linked to systemic inflammation [13], suggesting that a pro-inflammatory microenvironment in MM cells could drive APOBEC2 and APOBEC3B expression.